Valproic Acid

Valproic Acid

SCHEMBL4551299

CC(C)(CCc1ccccc1)C(=O)Nc1ccc(C(=O)NO)cc1.CCCC(CCC)C(=O)O

nearest known ligand 0.79

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ALDH5A1

The experimentally established mechanism targets of Valproic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 13/20 0.79
HDAC2 Q92769 9/20 0.79
HDAC8 Q9BY41 9/20 0.79
HDAC6 Q9UBN7 9/20 0.79
HDAC3 O15379 7/20 0.79
HDAC4 P56524 7/20 0.79
HDAC7 Q8WUI4 7/20 0.79
HDAC10 Q969S8 7/20 0.79
HDAC11 Q96DB2 7/20 0.79
HDAC9 Q9UKV0 7/20 0.79
HDAC5 Q9UQL6 7/20 0.79
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
TRPV1 Q8NER1 1/20 0.43
KDM4E B2RXH2 1/20 0.42
MAPT P10636 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL675237 0.89 HDAC1 (1.00) HDAC1HDAC2HDAC8HDAC6HDAC3
Ar-42 SCHEMBL2158594 0.80 HDAC1 (0.76) HDAC1HDAC2HDAC8HDAC6HDAC3
SCHEMBL673533 0.74 HDAC1 (0.71) HDAC1HDAC2HDAC8HDAC6HDAC3
SCHEMBL675454 0.71 HDAC1 (1.00) HDAC1HDAC2HDAC8HDAC6HDAC3
SCHEMBL22570424 0.71 HDAC2 (0.65) HDAC1HDAC2HDAC8HDAC6HDAC3
SCHEMBL1861360 0.70 GRIK1 (0.62) HDAC1HDAC2HDAC8HDAC6HDAC3
SCHEMBL1869110 0.69 HDAC1 (0.59) HDAC1HDAC2HDAC8HDAC3HDAC4
SCHEMBL5510828 0.69 GRIK1 (0.56) HDAC1HDAC2MAPT
SCHEMBL8284718 0.69 HDAC1 (0.60) HDAC1HDAC2HDAC8HDAC6HDAC3
SCHEMBL7440675 0.68 MEN1 (0.71) HDAC1HDAC2HDAC8HDAC6HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2040731-A2 SOLID ORAL DOSAGE FORM CONTAINING AN ENHANCER Merrion Research III Limited (IE) 2009-04-01 EP claimed
WO-2007146234-A2 SOLID ORAL DOSAGE FORM CONTAINING AN ENHANCER MERRION RESEARCH II LIMITED (IE) 2007-12-21 WO claimed